Polydextrose for the prevention and/or treatment of heart failure

Abstract

The present invention concerns polydextrose for use for preventing and/or treating heart failure in a subject.

1 . A method for preventing and/or treating heart failure in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of polydextrose. 
     
     
         2 . The method according to  claim 1 , wherein said heart failure is acute heart failure. 
     
     
         3 . The method according to  claim 1 ,
 wherein said heart failure is selected from left heart failure, right heart failure and global heart failure.   
     
     
         4 . The method according to  claim 1 , wherein said heart failure is selected from the group consisting of heart failure with ventricular systolic dysfunction and heart failure with preserved ventricular systolic function. 
     
     
         5 . The method according to  claim 1 , wherein said heart failure is of ischemic origin. 
     
     
         6 . The method according to  claim 1 , wherein said subject suffered from a myocardial infarction. 
     
     
         7 . The method according to  claim 1 , for preventing cardiac remodeling and/or ventricle dilatation. 
     
     
         8 . The method according to  claim 1 , for preventing systolic dysfunction. 
     
     
         9 . The method according to  claim 6 , wherein polydextrose is administered to said subject after myocardial infarction occurred. 
     
     
         10 . The method according to  claim 1 , wherein said polydextrose is purified polydextrose.